Press Releases: Four leading health care experts are generally optimistic that the U.S. will successfully address one of the fiercest challenges facing the health care system: paying for often spectacular, but high-cost gene and other curative therapies.
Partnership Forum: Industry leaders convened on October 19, 2017 to discuss this important issue. They found broad consensus on the importance of patient reported outcomes (PRO) in defining value.
Press Release: The perception of what is "valuable" in any particular therapy can vary widely between providers, patients and payers, according to panelists at the Academy of Managed Care Pharmacy (AMCP) Foundation's 7th Annual Research Symposium.
Conclusions reached in a recent New York Times article on outcomes-based contracting are premature, if not inaccurate, stated Academy of Managed Care Pharmacy (AMCP) CEO Susan A. Cantrell, RPh, CAE, adding, “It’s still the early innings for outcomes-based, or value-based, contracting for prescription drugs, and therefore, too soon to dismiss.”
Press Release: Diverse stakeholders representing managed care pharmacy, provider groups, integrated delivery systems and the biopharmaceutical industry this week developed key strategies to enable the expansion of “value-based contracting.”
Press Release: Increased collaboration, improved decision-making support tools and greater use of value-based contracting are among the recommendations to address the accelerating pace of oncology products coming to market each year.